The 1 analysts offering 12-month price forecasts for Zosano Pharma Corp have a median target of 21.00, with a high estimate of 21.00 and a low estimate of 21.00. The median estimate represents a +10,499,900.00% increase from the last price of 0.00.
The current consensus among 2 polled investment analysts is to Hold stock in Zosano Pharma Corp. This rating has held steady since May, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.70
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.